EUVIMEDEUVIMED entdecken
Crossref

Vorinostat Inhibition of FOXM1 Oncogenic Signaling Is Associated With the Downregulation of MYCN Transcription in Metastatic Retinoblastoma

Onyekwere Onwumere, Anastassiya Kim iD, Sual Lopez, Moira Sauane, Rebecca Yamraj, Cui Shi, Dianne Cox, Linda Saxe Einbond, Stephen Redenti, Rajendra Gharbaran iD

Journal of Biochemical and Molecular Toxicology · 2026-04 · 40 (4)

DOI: 10.1002/jbt.70834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 10.04.2026. Verfasst von Onyekwere Onwumere und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biology Doctoral Program, The Graduate School and University Center, City University of New York, New York, New York, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein M1, N-Myc Proto-Oncogene Protein, Retinoblastoma, Down-Regulation. Die Arbeit nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vorinostat (suberoylanilide hydroxamic acid, SAHA) is a histone deacetylase (HDAC) class I/II inhibitor that has been evaluated in clinical trials for efficacy in pediatric cancers. Previous studies demonstrated cellular responses to SAHA in retinoblastoma (RB), a pediatric intraocular cancer. However, its mechanism of action remains incompletely understood. In this report, we demonstrate that SAHA inhibition of cell proliferation and induction of cell death was associated with the downregulation of the FOXM1 oncogene in the MYCN‐driven RB1‐/RB1‐cell lines WERI‐RB1 and Y79, of which Y79 exhibits greater metastatic potential. SAHA also deregulated cell cycle genes that are targeted by FOXM1. Additionally, SAHA inhibited RB metastatic signaling, including inhibiting the expression of MMP2, a transcriptional target of FOXM1. Further, because SAHA inhibition of FOXM1 positively correlated with suppression of the MYCN oncogene, we demonstrated that genomic knockdown of MYCN in the RB cell lines resulted in FOXM1 downregulation. Finally, we showed that FOXM1 inhibition downregulated NF‐κβ and inhibition of FOXM1 suppressed FOXM1 expression in the RB cell lines. Taken together, these results indicated that SAHA inhibition of FOXM1 oncogenic signaling may be mediated by MYCN in RB. Although the current data provide a preclinical rationale for the consideration of SAHA either as a single agent or in combination with other therapies, for the treatment of metastatic RB with MYCN‐amplified RB1‐/RB1‐molecular phenotype, further research is warranted to gain greater insight into FOXM1‐MYCN interaction in response to SAHA, in this molecular subtype of RB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein M1N-Myc Proto-Oncogene ProteinRetinoblastomaDown-RegulationSignal TransductionHydroxamic AcidsGene Expression Regulation, NeoplasticTranscription, GeneticHistone Deacetylase InhibitorsVorinostatHumansCell Line, TumorCell ProliferationNeoplasm Metastasis

Stichwörter der Autor:innen

FOXM1MYCNhistone deacetylase inhibitormetastatic retinoblastomavorinostat

Substanzen

Forkhead Box Protein M1VorinostatN-Myc Proto-Oncogene ProteinFOXM1 protein, humanMYCN protein, humanHydroxamic AcidsHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Biology Doctoral Program, The Graduate School and University Center, City University of New York, New York, New York, USA.
  • Department of Biological Sciences, Lehman College/City University of New York, Bronx, New York, USA.
  • The Department of Nursing, Utica University, Utica, New York, USA.
  • Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, Bronx, New York, USA.
  • The New York Botanical Garden, Bronx, New York, USA.
  • Department of Biological Sciences, Bronx Community College/City University of New York, 2155 University Avenue, Bronx, New York, USA.

ORCID-Profile: Anastassiya Kim, Rajendra Gharbaran

Zitieren

APA

Onwumere, O., Kim, A., Lopez, S., Sauane, M., Yamraj, R., Shi, C., Cox, D., Einbond, L. S., Redenti, S., & Gharbaran, R. (2026). Vorinostat Inhibition of FOXM1 Oncogenic Signaling Is Associated With the Downregulation of MYCN Transcription in Metastatic Retinoblastoma. Journal of Biochemical and Molecular Toxicology, 40(4). https://doi.org/10.1002/jbt.70834

Vancouver

Onwumere O, Kim A, Lopez S, Sauane M, Yamraj R, Shi C, et al. Vorinostat Inhibition of FOXM1 Oncogenic Signaling Is Associated With the Downregulation of MYCN Transcription in Metastatic Retinoblastoma. Journal of Biochemical and Molecular Toxicology. 2026;40(4). doi:10.1002/jbt.70834

BibTeX
@article{Onwumere2026,
  author = {Onwumere, Onyekwere and Kim, Anastassiya and Lopez, Sual and Sauane, Moira and Yamraj, Rebecca and Shi, Cui and Cox, Dianne and Einbond, Linda Saxe and Redenti, Stephen and Gharbaran, Rajendra},
  title = {Vorinostat Inhibition of FOXM1 Oncogenic Signaling Is Associated With the Downregulation of MYCN Transcription in Metastatic Retinoblastoma},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {4},
  doi = {10.1002/jbt.70834}
}
Kostenlos starten →